Xin Geng

Title: Innovations of Xin Geng in Hepatitis B Treatment

Introduction

Xin Geng is an accomplished inventor based in Burlingame, CA (US). He has made significant contributions to the field of medical research, particularly in the treatment of hepatitis B virus (HBV) infection. With a total of 2 patents, his work focuses on developing effective methods and compositions for combating this viral infection.

Latest Patents

Xin Geng's latest patents include innovative compositions and methods for treating hepatitis B. The inventions provide methods for identifying compounds or compositions suitable for treating HBV infection. Additionally, they introduce a non-mammalian animal model that can be utilized to screen for compounds that inhibit HBV replication or treat HBV infection in mammals. Specifically, these inventions aim to treat hepatitis B infection by inhibiting the interaction between HBV x protein and a Bcl-2 family protein or by reducing the expression level of a Bcl-2 family protein.

Career Highlights

Xin Geng is affiliated with the University of Colorado, where he continues to advance his research in the field of virology. His work has garnered attention for its potential impact on public health, particularly in the management of hepatitis B.

Collaborations

Xin Geng collaborates with Ding Xue, who is also involved in research related to hepatitis B. Their partnership enhances the scope and depth of their research efforts.

Conclusion

Xin Geng's innovative work in developing treatments for hepatitis B showcases his dedication to improving health outcomes. His contributions to the field are significant and hold promise for future advancements in medical science.